共 245 条
[1]
Kannel WB(1979)Diabetes and cardiovascular disease. The Framingham Study JAMA 241 2035-2038
[2]
McGee DL(2007)Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study Circulation 115 1544-1550
[3]
Fox CS(2015)VADT Investigators. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes N. Engl. J. Med. 372 2197-2206
[4]
Coady S(1998)Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 703-713
[5]
Sorlie PD(2014)Report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 507-520
[6]
D’Agostino RB(1998)Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 854-865
[7]
Pencina MJ(2011)Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials Diabetes Obes. Metab. 13 221-228
[8]
Vasan RS(2015)Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes N. Engl. J. Med. 373 2117-2128
[9]
Meigs JB(2014)Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase Nature 510 542-546
[10]
Levy D(1996)Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance Hypertens. Res. 19 37-41